BioMarin Pharmaceutical’s (0HNC) Moving Averages Convergence Divergence (MACD) indicator is -0.37, suggesting BioMarin Pharmaceutical is a Sell.
BioMarin Pharmaceutical’s (0HNC) 20-Day exponential moving average is 56.83, while BioMarin Pharmaceutical’s (0HNC) share price is $57.86, making it a Buy.
BioMarin Pharmaceutical’s (0HNC) 50-Day exponential moving average is 58.33, while BioMarin Pharmaceutical’s (0HNC) share price is $57.86, making it a Sell.
BioMarin Pharmaceutical’s (0HNC) 10-Day exponential moving average is 56.79, while BioMarin Pharmaceutical’s (0HNC) share price is $57.86, making it a Buy.
BioMarin Pharmaceutical’s (0HNC) 100-Day exponential moving average is 59.03, while BioMarin Pharmaceutical’s (0HNC) share price is $57.86, making it a Sell.
BioMarin Pharmaceutical’s (0HNC) stock price is $57.86 and BioMarin Pharmaceutical’s (0HNC) 50-day simple moving average is 59.28, creating a Sell signal.
BioMarin Pharmaceutical’s (0HNC) stock price is $57.86 and BioMarin Pharmaceutical’s (0HNC) 100-day simple moving average is 60.64, creating a Sell signal.
BioMarin Pharmaceutical’s (0HNC) stock price is $57.86 and BioMarin Pharmaceutical’s (0HNC) 200-day simple moving average is 58.51, creating a Sell signal.